ISPE President and CEO Thomas B.
Hartman has announced his intentions to retire from ISPE in
early fall 2024. A search committee has been formed to identify a
new CEO.
NORTH
BETHESDA, Md., May 17, 2024
/PRNewswire-PRWeb/ -- The International Society for Pharmaceutical
Engineering (ISPE) International Board of Directors has announced
the retirement of Thomas B. Hartman,
President and CEO of ISPE. Mr. Hartman will stay on until early
fall to ensure a smooth transition.
Hartman has served ISPE with unparalleled dedication and
leadership for four years, guiding the nonprofit through
significant milestones and achievements. Under his direction, ISPE
has flourished, expanding its presence in the pharmaceutical
industry to over 22,000 members and enhancing its reputation as a
thought leader in shaping the future of the pharmaceutical
industry.
"I joined ISPE as President and CEO, following my initial plans
for retirement after a long and fulfilling career in the
pharmaceutical industry," said Hartman. "I look forward to
supporting ISPE through this transition and to my retirement. I
thank the ISPE International Board, staff, and membership for their
support and for what we have accomplished together over the past
four years and have full confidence that the vibrant ISPE community
will continue to thrive."
Prior to taking on the role of President and CEO of ISPE,
Hartman had served for nearly seven years on ISPE's International
Board of Directors. He has been a member of ISPE since 2001.
"We respect the decision Tom has made to share his plans for
retirement. ISPE has enjoyed record-level growth under Tom's
steadfast leadership, and we express our sincere gratitude to his
outstanding contributions during his many years of service to the
organization," said Scott W.
Billman, ISPE International Board of Directors, Chair and
Vice President of Global Engineering, Real Estate, and Facilities
for Solventum. "Our search committee has already begun the process
of identifying a qualified successor for the role. We have
comprehensive vetting plans in place and look forward to building
upon Tom's legacy as well as helping to elevate ISPE to new
heights."
ISPE remains committed to its mission of being a global industry
leader in connecting pharmaceutical knowledge to deliver
manufacturing and supply chain innovation, operational excellence,
and regulatory insights to enhance industry efforts to develop,
manufacture and reliably deliver quality medicines to patients. To
learn more about ISPE, visit ISPE.org.
About ISPE
The International Society for Pharmaceutical Engineering (ISPE) is
a global nonprofit association serving its members through leading
scientific, technical, and regulatory advancement across the entire
pharmaceutical lifecycle. The 22,000+ members of ISPE provide
solutions to complex pharmaceutical industry challenges through
innovation, member and workforce development, and technical,
regulatory, and compliance collaborations in more than 120
countries worldwide. Founded in 1980, ISPE has its worldwide
headquarters and training center in North
Bethesda, Maryland, USA, and its operations center in
Tampa, Florida, USA. For more
information, visit ISPE.org.
Media Contact
Katie LeChase, ISPE,
+1-360-718-9771, KLeChase@ISPE.org, https://ispe.org/
View original
content:https://www.prweb.com/releases/ispe-international-board-of-directors-announces-the-retirement-of-thomas-b-hartman-president-and-ceo-of-ispe-302148556.html
SOURCE ISPE